Will Antiarrhythmic Drug Therapy Guided by Electrophysiology Study Survive in the New Millennium?

1. Scherlag BJ , Lau SH , Helfant RH , et al. Catheter technique for recording His bundle activity in man. Circulation 39:13-13, 1969

2. Durrer D , Schoo L , Schuilenburg RM , et al. The role of premature beats in the initiation and the termination of supraventricular tachycardias in the W.P.W syndrome. Circulation 36:644-644, 1967

3. Wellens HJJ . Electrical Stimulation of the Heart in the Study and Treatment of Tachycardias. Baltimore, University Park Press, 1971

4. Wu D , Wyndham CR , Denes P , et al. Chronic electrophysiological study in patients with recurrent paroxysmal tachycardia: A new method for developing successful oral antiarrhythmic therapy. In Kulbertus H (ed). Re-entrant Arrhythmias: Mechanisms and Treatment. University Park Press, Baltimore, 1976

5. Hartzler GO , Maloney JD . Programmed ventricular stimulation in management of recurrent ventricular tachycardia. Mayo Clin 52:731-741, 1977

6. Fisher JD , Cohen HL , Mehra R , et al. Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J 93:658-668, 1977

7. Mason JW , Winkle RA . Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 58:971-985, 1978

8. Horowitz LN , Josephson ME , Farshidi A , et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986-997, 1978

9. Friedman L , Yusuf S . Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response? Circulation 73:II-59-66, 1986

10. Woosley RL . The role of programmed electrical stimulation in the evaluation of investigational antiarrhythmic drugs: Overview of the workshop. Circulation 73:II-112-113, 1986

11. Lown B , Graboys TB , Podrid PJ , et al. Historic perspectives-electrical stimulation of the heart. Circulation 73:II-3-10, 1986

12. Gaboys TB , Lown B , Podrid PHJ , et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 50:437-443, 1982

13. Mitchell BL , Duff HJ , Manyari DE , et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med 317:1681-1687, 1987

14. Mason JW for the ESVEM investigators . A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 329:445-451, 1993

15. Mitchell BL , Sheldon RS , Gillis AM , et al. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: Randomized comparison of patient response criteria. J Am Coll Cardiol 30:1346-1353, 1997

16. Buxton AE , Lee KL , Fisher JD , et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N EngI J Med 341:1882-1890, 1999

17. Moss AJ , Hall WJ , Cannom IDS , et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 3351:1933-1940, 1996